Variant report
Variant | nsv437421 |
---|---|
Chromosome Location | chr4:121090040-121113162 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:120985495..120988183-chr4:121111194..121113222,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC110373.1-12 | chr4:121102663-121102842 | NONHSAT098121 |
2 | lnc-AC110373.1-12 | chr4:121103326-121103369 | NONHSAT098121 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250938 | chromatin interactions |
ENSG00000164109 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149923311 | chr4:121090807-121090808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532660220 | chr4:121090815-121090816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539416351 | chr4:121090862-121090863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552415189 | chr4:121090896-121090897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181019115 | chr4:121090911-121090912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75213690 | chr4:121090937-121090938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs185046996 | chr4:121090957-121090958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552698659 | chr4:121090968-121090969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572857547 | chr4:121090995-121090996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72918143 | chr4:121091011-121091012 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs568517315 | chr4:121091020-121091021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74875230 | chr4:121091079-121091080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557311116 | chr4:121091107-121091108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537346451 | chr4:121091230-121091231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372107001 | chr4:121091269-121091270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539844472 | chr4:121091286-121091287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72918144 | chr4:121091329-121091330 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs572385258 | chr4:121091388-121091389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138890292 | chr4:121096648-121096649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552868328 | chr4:121096698-121096699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191237587 | chr4:121096710-121096711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs80177145 | chr4:121096784-121096785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568563814 | chr4:121096919-121096920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548400242 | chr4:121096924-121096925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527245125 | chr4:121096974-121096975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547110587 | chr4:121097039-121097040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567925726 | chr4:121097057-121097058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368122105 | chr4:121097105-121097106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530372829 | chr4:121097108-121097109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550339326 | chr4:121097120-121097121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181901121 | chr4:121097135-121097136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141459749 | chr4:121097154-121097155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537556671 | chr4:121097160-121097161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558598308 | chr4:121097211-121097212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565853241 | chr4:121097268-121097269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535003556 | chr4:121097305-121097306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186916819 | chr4:121097310-121097311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17011279 | chr4:121097313-121097314 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs542599510 | chr4:121097327-121097328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556509960 | chr4:121097386-121097387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191161679 | chr4:121097393-121097394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79981610 | chr4:121097394-121097395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570171750 | chr4:121097417-121097418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200658412 | chr4:121097468-121097469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564956429 | chr4:121097555-121097556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565815997 | chr4:121097566-121097567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35739693 | chr4:121097586-121097587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527422355 | chr4:121097621-121097622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541017219 | chr4:121097631-121097632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558296513 | chr4:121097637-121097638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Clear cell renal cell carcinoma | 18791270 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Gastric cancer | 16891809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:121090800-121091400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:121096600-121097000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr4:121097000-121097200 | Enhancers | Psoas Muscle | Psoas |
4 | chr4:121097200-121103000 | Weak transcription | Psoas Muscle | Psoas |
5 | chr4:121103000-121103800 | ZNF genes & repeats | Psoas Muscle | Psoas |
6 | chr4:121105200-121108000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr4:121112800-121113200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |